Zealand University Hospital
Welcome,         Profile    Billing    Logout  
 27 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gögenur, Ismail
MEFO, NCT04312360: Preoperative Endoscopic Treatment With Fosfomycin and Metronidazole in Patients With Right-sided Colon Cancer and Colon Adenoma (-trial)

Completed
2
28
Europe
therapeutic endoscopy with metronidazole and fosfomycin disodium
Zealand University Hospital, Costerton Biofilm Center, Reponex Pharmaceuticals A/S, Region Zealand
Right-sided Colon Cancer, Right-sided Colon Adenoma
04/22
07/23
Hasselbalch, Hans C
ERNEST-3, NCT06533813: Clinical Epidemiology in Contemporary Patients With Myelofibrosis.

Not yet recruiting
N/A
617
Europe, RoW
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, GlaxoSmithKline
Myelofibrosis
12/24
12/28
Vind, Ida
NCT04469686 / 2019-003596-19: Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Completed
3
200
US
Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator, Twice Daily - Active, Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator, Once Daily - Active, Twice daily placebo suppository administered with Sephure applicator, Twice Daily - Placebo
Cristcot LLC, Cristcot HCA LLC
Ulcerative Proctitis
07/24
09/24
Nielsen, Jesper B
NCT06120153: Point of Care Polymerase Chain Reaction (PCR) Diagnostics of Respiratory Tract Infections in General Practice

Recruiting
N/A
5700
Europe
POC PCR-test device
University of Southern Denmark, Roche Diagnostics
Respiratory Tract Infections
04/24
03/30
Nikolov, Nikolay
NCT04469686 / 2019-003596-19: Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Completed
3
200
US
Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator, Twice Daily - Active, Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator, Once Daily - Active, Twice daily placebo suppository administered with Sephure applicator, Twice Daily - Placebo
Cristcot LLC, Cristcot HCA LLC
Ulcerative Proctitis
07/24
09/24
Vester-Anderson, Marianne
NCT04469686 / 2019-003596-19: Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Completed
3
200
US
Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator, Twice Daily - Active, Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator, Once Daily - Active, Twice daily placebo suppository administered with Sephure applicator, Twice Daily - Placebo
Cristcot LLC, Cristcot HCA LLC
Ulcerative Proctitis
07/24
09/24
Abildgaard, Katrine R
No trials found
Buxbom, Peter
No trials found
Deshmukh, Aviraj
No trials found
Lassen, Karsten Lomholt
No trials found
Philipsen, Annelotte
No trials found
Kalmriz, Malik
No trials found
Kjelkvist-Born, Camilla
No trials found

Download Options